Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3100Neoplasms 2446Carcinoma, Non-Small-Cell Lung 1865Prostatic Neoplasms 1629Colorectal Neoplasms 1424Lung Neoplasms 1300Multiple Myeloma 930Neoplasm Metastasis 926Leukemia, Myeloid, Acute 874Pancreatic Neoplasms 851Ovarian Neoplasms 803Melanoma 786Carcinoma, Hepatocellular 743Stomach Neoplasms 640Brain Neoplasms 640Recurrence 635Squamous Cell Carcinoma of Head and Neck 631Head and Neck Neoplasms 614Glioblastoma 569Lymphoma 543Uterine Cervical Neoplasms 541Triple Negative Breast Neoplasms 505Precursor Cell Lymphoblastic Leukemia-Lymphoma 498Carcinoma, Renal Cell 497Hematologic Neoplasms 467Urinary Bladder Neoplasms 462Endometrial Neoplasms 462Colonic Neoplasms 439Sarcoma 437Lymphoma, Non-Hodgkin 437

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Smith-Magenis Syndrome × 1 year × Clear all
NCT03836300 2025-07-31

Parent and Infant Inter(X)Action Intervention (PIXI)

RTI International

Phase NA Enrolling by invitation
120 enrolled

Telomeric 22q13 Monosomy Syndrome, Developmental Disabilities, DiGeorge Syndrome, Down Syndrome, Fragile X Syndrome, Klinefelter Syndrome, Prader-Willi Syndrome, Tuberous Sclerosis, Turner Syndrome, Rett Syndrome, Angelman Syndrome, Williams Syndrome, Muscular Dystrophy, Duchenne, Smith-Magenis Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡